| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |